Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
46 studies found for:    "quality of life" AND "HIV infections " [CONDITION ] | Open Studies
Show Display Options
Rank Status Study
21 Not yet recruiting Validation Study of mHealth Technology in HIV to Improve Empowerment and Healthcare Utilisation: Research and Innovation to Generate Evidence for Personalised Care (EmERGE)
Condition: HIV Infections
Intervention: Other: mHealth platform
22 Recruiting A Sleep Program to Improve Sleep Quality in People With HIV
Conditions: HIV - Human Immunodeficiency Virus;   Insomnia Disorder
Intervention: Behavioral: Digital cognitive behavioural therapy for insomnia (dCBT-I)
23 Recruiting Healing Hearts and Mending Minds in Older Adults Living With HIV
Conditions: HIV;   Cardiovascular Disease;   AIDS
Interventions: Behavioral: Let's Move Program;   Behavioral: Let's Flex Program;   Behavioral: Group Motivational Interviewing
24 Recruiting STRIBILD in Non-Nucleoside Resistant Patients (SINNR STUDY)
Conditions: HIV;   Illicit Drug User
Intervention: Drug: STRIBILD
25 Recruiting Mindfulness Based Stress Reduction for Older Adults With HIV Associated Neurocognitive Disorders
Conditions: Impaired Cognition;   HIV Infection
Intervention: Behavioral: MBSR
26 Not yet recruiting Developing and Assessing a Community Based Model of Antiretroviral Care
Condition: HIV
Intervention: Other: community-based care
27 Recruiting Strategy for Maintenance of HIV Suppression With Elvitegravir + Darunavir/Ritonavir in Children
Condition: HIV Infection
Interventions: Drug: EVG +DRV/r;   Drug: SOC
28 Recruiting Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa
Conditions: Hepatitis C;   HIV Infection
Interventions: Drug: Sofosbuvir;   Drug: Ribavirin;   Drug: Ledipasvir
29 Recruiting Translation Evaluation of Aging, Inflammation and HIV in Lung Function (TEAL)
Conditions: HIV;   COPD;   Pulmonary Disease;   Aging
Interventions: Procedure: PFT;   Procedure: lab work;   Procedure: 6MWT;   Other: questionnaires
30 Not yet recruiting Triumeq As an Integrase Single Tablet Regimen in People With HIV Who Inject Drugs
Condition: Human Immunodeficiency Virus
Intervention: Drug: dolutegravir/abacavir/lamivudine
31 Recruiting An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 2)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir (DTG);   Drug: Lamivudine (3TC);   Drug: Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC)
32 Recruiting An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir (DTG);   Drug: Lamivudine (3TC);   Drug: Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC)
33 Recruiting Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Cabotegravir (CAB) tablet;   Drug: Rilpivirine (RPV) tablet;   Drug: Cabotegravir - Injectable Suspension (CAB LA);   Drug: Rilpivirine - Injectable Suspension (RPV LA);   Drug: ABC/DTG/3TC STR - Tablet;   Drug: DTG Tablet
34 Recruiting Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Cabotegravir (CAB) tablet;   Drug: Rilpivirine (RPV) tablet;   Drug: Cabotegravir - Injectable Suspension (CAB LA);   Drug: Rilpivirine - Injectable Suspension (RPV LA);   Drug: 2 NRTIs plus an INI, NNRTI, or PI
35 Recruiting PATH For Triples Study: Medication and Lifestyle Adherence for HIV+ Patients
Condition: HIV
Interventions: Behavioral: PATH For Triples;   Behavioral: Treatment as Usual
36 Recruiting Study to Evaluate the Efficacy of MONotherapy of TiviCAY® Versus a Triple Therapy in HIV-1-infected Patients
Condition: HIV
Interventions: Drug: dolutegravir 50mg +abacavir 600mg +lamivudine 300mg;   Drug: dolutegravir
37 Recruiting Darunavir/Ritonavir + Lamivudine Versus Darunavir/Ritonavir +Emtricitabine/Tenofovir in Naïve HIV-1 Infected Subjects
Condition: HIV-1 Infection
Interventions: Drug: darunavir/ritonavir;   Drug: Lamivudine;   Drug: emtricitabine-tenofovir(FTC/TDF)
38 Recruiting Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS
Condition: HIV-1 Infection
Interventions: Drug: Coformulated EFV/FTC/TDF;   Drug: Etoposide;   Drug: Bleomycin and Vincristine (BV);   Drug: Paclitaxel (PTX)
39 Recruiting Ondansetron, Alcohol Use, and Alcohol-Related Symptoms In HIV+ Persons
Conditions: Alcohol Abuse;   Alcohol Dependence
Interventions: Drug: ondansetron;   Drug: placebo ondansetron;   Drug: Ondansetron
40 Recruiting Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resource-limited Settings
Condition: HIV-1 Infection
Interventions: Drug: Dolutegravir 50 mg;   Drug: Tenofovir disoproxil fumarate 300 mg / lamivudine 300 mg;   Drug: Efavirenz 200 mg

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-46) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.